2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma
Clinical trial NCT03168100 · WITHDRAWN
Trial details
- NCT number
- NCT03168100
- Sponsor
- University of Arkansas
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-01
- Primary completion
- 2019-01-24
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.